Velard Frédéric is an Ingénieur de Recherche at URCA, specializing in biology with a focus on rare bone diseases and bioengineering since 2015. Velard's research interests include CF-related Bone Disease, bone dysplasia, and inflammatory processes. They co-founded VG2D Pharma in 2023, contributing to advancements in biologics. Having completed a PhD and post-doctoral research, Velard has extensive experience in studying inflammatory responses and the impact of various treatments on bone conditions. Velard holds a degree from Université de Reims Champagne-Ardenne, where they furthered their expertise during 2016-2017.
Location
Reims, France
Links
This person is not in the org chart
This person is not in any teams
This person is not in any offices